Pendium

Step 1 of 9

Noom is a category leader for habit change, but the clinical GLP-1 race is tightening.

Your brand owns the 'psychology' narrative in AI responses. Here is where you can expand into clinical and metabolic health leadership.

Noom's baseline score
76/100
Good

Noom maintains a formidable presence in AI recommendations for behavioral weight loss. While its legacy as a psychology-based app is secure, there is a clear opportunity to capture more visibility in the rapidly growing medical weight loss and GLP-1 companion categories.

What we see
  • Noom has an exceptionally strong 'canonical' signal in ChatGPT and Claude due to years of editorial coverage in major publications.
  • The pivot to GLP-1 is well-documented, but younger startups like Ro and Calibrate currently have more aggressive 'clinical' visibility in Google AI Overviews.
  • Reddit sentiment remains a key driver for Gemini and AI Overviews, where Noom is often praised for its psychological approach but critiqued for its subscription model.
  • A significant visibility gap exists in 'metabolic health' prompts where Oura or Levels are more frequently cited than Noom.
Business goals Noom is likely trying to hit
  • Drive adoption of the Noom Med clinical GLP-1 program
  • Differentiate behavioral psychology approach from basic calorie counting apps
  • Increase long-term retention through community and habit-tracking features